JP Patent

JP6325148B2 — 注意欠陥障害の処置のための方法および組成物

Assigned to アイアンショアファーマシューティカルズアンドディベロップメント，インコーポレイテッド · Expires 2018-05-16 · 8y expired

What this patent protects

Patent listed against methylphenidate-hydrochloride.

Drugs covered by this patent

methylphenidate-hydrochloride (METHYLPHENIDATE HYDROCHLORIDE)

Patent Metadata

Patent number: JP6325148B2
Jurisdiction: JP
Classification: —
Expires: 2018-05-16
Drug substance claim: No
Drug product claim: No
Assignee: アイアンショアファーマシューティカルズアンドディベロップメント，インコーポレイテッド
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.